nodes	percent_of_prediction	percent_of_DWPC	metapath
Rufinamide—ALB—Prednisone—ankylosing spondylitis	0.183	0.236	CbGbCtD
Rufinamide—CYP2E1—Dexamethasone—ankylosing spondylitis	0.118	0.153	CbGbCtD
Rufinamide—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0947	0.122	CbGbCtD
Rufinamide—ALB—Methotrexate—ankylosing spondylitis	0.0919	0.118	CbGbCtD
Rufinamide—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0718	0.0926	CbGbCtD
Rufinamide—CYP3A4—Betamethasone—ankylosing spondylitis	0.0616	0.0794	CbGbCtD
Rufinamide—CYP3A4—Prednisolone—ankylosing spondylitis	0.0608	0.0784	CbGbCtD
Rufinamide—CYP3A4—Prednisone—ankylosing spondylitis	0.0574	0.074	CbGbCtD
Rufinamide—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0358	0.0462	CbGbCtD
Rufinamide—Epilepsy—Dexamethasone—ankylosing spondylitis	0.00666	0.0296	CcSEcCtD
Rufinamide—Epilepsy—Betamethasone—ankylosing spondylitis	0.00666	0.0296	CcSEcCtD
Rufinamide—Ear infection—Triamcinolone—ankylosing spondylitis	0.00657	0.0292	CcSEcCtD
Rufinamide—Epilepsy—Prednisone—ankylosing spondylitis	0.0058	0.0258	CcSEcCtD
Rufinamide—Acne—Prednisolone—ankylosing spondylitis	0.00361	0.0161	CcSEcCtD
Rufinamide—Acne—Triamcinolone—ankylosing spondylitis	0.00332	0.0148	CcSEcCtD
Rufinamide—Acne—Methylprednisolone—ankylosing spondylitis	0.00331	0.0147	CcSEcCtD
Rufinamide—Acne—Dexamethasone—ankylosing spondylitis	0.00301	0.0134	CcSEcCtD
Rufinamide—Acne—Betamethasone—ankylosing spondylitis	0.00301	0.0134	CcSEcCtD
Rufinamide—Contusion—Dexamethasone—ankylosing spondylitis	0.0029	0.0129	CcSEcCtD
Rufinamide—Contusion—Betamethasone—ankylosing spondylitis	0.0029	0.0129	CcSEcCtD
Rufinamide—Acne—Prednisone—ankylosing spondylitis	0.00262	0.0117	CcSEcCtD
Rufinamide—Contusion—Prednisone—ankylosing spondylitis	0.00253	0.0112	CcSEcCtD
Rufinamide—Increased appetite—Prednisolone—ankylosing spondylitis	0.00235	0.0104	CcSEcCtD
Rufinamide—Increased appetite—Triamcinolone—ankylosing spondylitis	0.00216	0.0096	CcSEcCtD
Rufinamide—Increased appetite—Methylprednisolone—ankylosing spondylitis	0.00215	0.00957	CcSEcCtD
Rufinamide—Bone disorder—Methotrexate—ankylosing spondylitis	0.00204	0.00908	CcSEcCtD
Rufinamide—Increased appetite—Dexamethasone—ankylosing spondylitis	0.00196	0.00871	CcSEcCtD
Rufinamide—Increased appetite—Betamethasone—ankylosing spondylitis	0.00196	0.00871	CcSEcCtD
Rufinamide—Breast disorder—Methylprednisolone—ankylosing spondylitis	0.00183	0.00813	CcSEcCtD
Rufinamide—Influenza—Triamcinolone—ankylosing spondylitis	0.00175	0.00779	CcSEcCtD
Rufinamide—Increased appetite—Prednisone—ankylosing spondylitis	0.0017	0.00758	CcSEcCtD
Rufinamide—Bronchitis—Triamcinolone—ankylosing spondylitis	0.00168	0.00749	CcSEcCtD
Rufinamide—Urine output increased—Methotrexate—ankylosing spondylitis	0.00167	0.00742	CcSEcCtD
Rufinamide—Lymphadenopathy—Methotrexate—ankylosing spondylitis	0.00157	0.00698	CcSEcCtD
Rufinamide—Infestation NOS—Methylprednisolone—ankylosing spondylitis	0.00156	0.00693	CcSEcCtD
Rufinamide—Infestation—Methylprednisolone—ankylosing spondylitis	0.00156	0.00693	CcSEcCtD
Rufinamide—Polyuria—Methotrexate—ankylosing spondylitis	0.00152	0.00678	CcSEcCtD
Rufinamide—Epistaxis—Triamcinolone—ankylosing spondylitis	0.00147	0.00655	CcSEcCtD
Rufinamide—Weight decreased—Betamethasone—ankylosing spondylitis	0.00144	0.0064	CcSEcCtD
Rufinamide—Weight decreased—Dexamethasone—ankylosing spondylitis	0.00144	0.0064	CcSEcCtD
Rufinamide—Rhinitis—Triamcinolone—ankylosing spondylitis	0.00141	0.00625	CcSEcCtD
Rufinamide—Rhinitis—Methylprednisolone—ankylosing spondylitis	0.0014	0.00624	CcSEcCtD
Rufinamide—Eye disorder—Methylprednisolone—ankylosing spondylitis	0.00131	0.00582	CcSEcCtD
Rufinamide—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.0013	0.00578	CcSEcCtD
Rufinamide—Neutropenia—Prednisone—ankylosing spondylitis	0.00129	0.00576	CcSEcCtD
Rufinamide—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.00126	0.00562	CcSEcCtD
Rufinamide—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.00126	0.00561	CcSEcCtD
Rufinamide—Ataxia—Methotrexate—ankylosing spondylitis	0.00126	0.0056	CcSEcCtD
Rufinamide—Weight decreased—Prednisone—ankylosing spondylitis	0.00125	0.00557	CcSEcCtD
Rufinamide—Vision blurred—Prednisolone—ankylosing spondylitis	0.00125	0.00556	CcSEcCtD
Rufinamide—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.00123	0.00545	CcSEcCtD
Rufinamide—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.00122	0.00542	CcSEcCtD
Rufinamide—Breast disorder—Methotrexate—ankylosing spondylitis	0.00121	0.00538	CcSEcCtD
Rufinamide—Vertigo—Prednisolone—ankylosing spondylitis	0.00119	0.0053	CcSEcCtD
Rufinamide—Eye disorder—Dexamethasone—ankylosing spondylitis	0.00119	0.00529	CcSEcCtD
Rufinamide—Eye disorder—Betamethasone—ankylosing spondylitis	0.00119	0.00529	CcSEcCtD
Rufinamide—Back pain—Triamcinolone—ankylosing spondylitis	0.00118	0.00525	CcSEcCtD
Rufinamide—Convulsion—Prednisolone—ankylosing spondylitis	0.00115	0.00512	CcSEcCtD
Rufinamide—Vertigo—Triamcinolone—ankylosing spondylitis	0.0011	0.00488	CcSEcCtD
Rufinamide—Vertigo—Methylprednisolone—ankylosing spondylitis	0.00109	0.00487	CcSEcCtD
Rufinamide—Neutropenia—Methotrexate—ankylosing spondylitis	0.00108	0.00481	CcSEcCtD
Rufinamide—Dysuria—Methotrexate—ankylosing spondylitis	0.00108	0.00481	CcSEcCtD
Rufinamide—Convulsion—Triamcinolone—ankylosing spondylitis	0.00106	0.0047	CcSEcCtD
Rufinamide—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00106	0.00469	CcSEcCtD
Rufinamide—Pneumonia—Methotrexate—ankylosing spondylitis	0.00104	0.00462	CcSEcCtD
Rufinamide—Eye disorder—Prednisone—ankylosing spondylitis	0.00104	0.00461	CcSEcCtD
Rufinamide—Anxiety—Methylprednisolone—ankylosing spondylitis	0.00103	0.0046	CcSEcCtD
Rufinamide—Infestation NOS—Methotrexate—ankylosing spondylitis	0.00103	0.00459	CcSEcCtD
Rufinamide—Infestation—Methotrexate—ankylosing spondylitis	0.00103	0.00459	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00103	0.00458	CcSEcCtD
Rufinamide—Immune system disorder—Prednisone—ankylosing spondylitis	0.001	0.00445	CcSEcCtD
Rufinamide—Vertigo—Dexamethasone—ankylosing spondylitis	0.000995	0.00443	CcSEcCtD
Rufinamide—Vertigo—Betamethasone—ankylosing spondylitis	0.000995	0.00443	CcSEcCtD
Rufinamide—Infection—Triamcinolone—ankylosing spondylitis	0.00099	0.0044	CcSEcCtD
Rufinamide—Infection—Methylprednisolone—ankylosing spondylitis	0.000987	0.00439	CcSEcCtD
Rufinamide—Haematuria—Methotrexate—ankylosing spondylitis	0.000983	0.00437	CcSEcCtD
Rufinamide—Insomnia—Prednisolone—ankylosing spondylitis	0.00098	0.00436	CcSEcCtD
Rufinamide—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000976	0.00434	CcSEcCtD
Rufinamide—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000975	0.00434	CcSEcCtD
Rufinamide—Epistaxis—Methotrexate—ankylosing spondylitis	0.000973	0.00433	CcSEcCtD
Rufinamide—Mental disorder—Prednisone—ankylosing spondylitis	0.000971	0.00432	CcSEcCtD
Rufinamide—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000965	0.00429	CcSEcCtD
Rufinamide—Malnutrition—Prednisone—ankylosing spondylitis	0.000965	0.00429	CcSEcCtD
Rufinamide—Convulsion—Dexamethasone—ankylosing spondylitis	0.00096	0.00427	CcSEcCtD
Rufinamide—Convulsion—Betamethasone—ankylosing spondylitis	0.00096	0.00427	CcSEcCtD
Rufinamide—Anxiety—Dexamethasone—ankylosing spondylitis	0.00094	0.00418	CcSEcCtD
Rufinamide—Anxiety—Betamethasone—ankylosing spondylitis	0.00094	0.00418	CcSEcCtD
Rufinamide—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000914	0.00407	CcSEcCtD
Rufinamide—Vision blurred—Prednisone—ankylosing spondylitis	0.000909	0.00404	CcSEcCtD
Rufinamide—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000908	0.00404	CcSEcCtD
Rufinamide—Insomnia—Triamcinolone—ankylosing spondylitis	0.000901	0.00401	CcSEcCtD
Rufinamide—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000899	0.004	CcSEcCtD
Rufinamide—Infection—Dexamethasone—ankylosing spondylitis	0.000898	0.00399	CcSEcCtD
Rufinamide—Infection—Betamethasone—ankylosing spondylitis	0.000898	0.00399	CcSEcCtD
Rufinamide—Anaemia—Prednisone—ankylosing spondylitis	0.000891	0.00397	CcSEcCtD
Rufinamide—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000886	0.00394	CcSEcCtD
Rufinamide—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000886	0.00394	CcSEcCtD
Rufinamide—Agitation—Prednisone—ankylosing spondylitis	0.000886	0.00394	CcSEcCtD
Rufinamide—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000885	0.00394	CcSEcCtD
Rufinamide—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000885	0.00394	CcSEcCtD
Rufinamide—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000877	0.0039	CcSEcCtD
Rufinamide—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000875	0.00389	CcSEcCtD
Rufinamide—Vertigo—Prednisone—ankylosing spondylitis	0.000867	0.00385	CcSEcCtD
Rufinamide—Eye disorder—Methotrexate—ankylosing spondylitis	0.000865	0.00385	CcSEcCtD
Rufinamide—Anorexia—Dexamethasone—ankylosing spondylitis	0.000862	0.00383	CcSEcCtD
Rufinamide—Anorexia—Betamethasone—ankylosing spondylitis	0.000862	0.00383	CcSEcCtD
Rufinamide—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000859	0.00382	CcSEcCtD
Rufinamide—Fatigue—Triamcinolone—ankylosing spondylitis	0.000859	0.00382	CcSEcCtD
Rufinamide—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000857	0.00381	CcSEcCtD
Rufinamide—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000836	0.00372	CcSEcCtD
Rufinamide—Convulsion—Prednisone—ankylosing spondylitis	0.000836	0.00372	CcSEcCtD
Rufinamide—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000835	0.00371	CcSEcCtD
Rufinamide—Anxiety—Prednisone—ankylosing spondylitis	0.000818	0.00364	CcSEcCtD
Rufinamide—Insomnia—Betamethasone—ankylosing spondylitis	0.000818	0.00364	CcSEcCtD
Rufinamide—Insomnia—Dexamethasone—ankylosing spondylitis	0.000818	0.00364	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000815	0.00363	CcSEcCtD
Rufinamide—Mental disorder—Methotrexate—ankylosing spondylitis	0.000811	0.00361	CcSEcCtD
Rufinamide—Malnutrition—Methotrexate—ankylosing spondylitis	0.000806	0.00359	CcSEcCtD
Rufinamide—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000798	0.00355	CcSEcCtD
Rufinamide—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000796	0.00354	CcSEcCtD
Rufinamide—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000796	0.00354	CcSEcCtD
Rufinamide—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000786	0.0035	CcSEcCtD
Rufinamide—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000786	0.0035	CcSEcCtD
Rufinamide—Infection—Prednisone—ankylosing spondylitis	0.000782	0.00348	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00078	0.00347	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00078	0.00347	CcSEcCtD
Rufinamide—Back pain—Methotrexate—ankylosing spondylitis	0.00078	0.00347	CcSEcCtD
Rufinamide—Fatigue—Dexamethasone—ankylosing spondylitis	0.000779	0.00347	CcSEcCtD
Rufinamide—Fatigue—Betamethasone—ankylosing spondylitis	0.000779	0.00347	CcSEcCtD
Rufinamide—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000772	0.00343	CcSEcCtD
Rufinamide—Skin disorder—Prednisone—ankylosing spondylitis	0.000765	0.0034	CcSEcCtD
Rufinamide—Vision blurred—Methotrexate—ankylosing spondylitis	0.00076	0.00338	CcSEcCtD
Rufinamide—Anorexia—Prednisone—ankylosing spondylitis	0.00075	0.00334	CcSEcCtD
Rufinamide—Anaemia—Methotrexate—ankylosing spondylitis	0.000745	0.00331	CcSEcCtD
Rufinamide—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000734	0.00326	CcSEcCtD
Rufinamide—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000732	0.00326	CcSEcCtD
Rufinamide—Vertigo—Methotrexate—ankylosing spondylitis	0.000724	0.00322	CcSEcCtD
Rufinamide—Leukopenia—Methotrexate—ankylosing spondylitis	0.000722	0.00321	CcSEcCtD
Rufinamide—Dizziness—Prednisolone—ankylosing spondylitis	0.000716	0.00319	CcSEcCtD
Rufinamide—Asthenia—Triamcinolone—ankylosing spondylitis	0.000715	0.00318	CcSEcCtD
Rufinamide—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000713	0.00317	CcSEcCtD
Rufinamide—Insomnia—Prednisone—ankylosing spondylitis	0.000712	0.00317	CcSEcCtD
Rufinamide—Pruritus—Triamcinolone—ankylosing spondylitis	0.000705	0.00314	CcSEcCtD
Rufinamide—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000703	0.00313	CcSEcCtD
Rufinamide—Convulsion—Methotrexate—ankylosing spondylitis	0.000698	0.00311	CcSEcCtD
Rufinamide—Dyspepsia—Prednisone—ankylosing spondylitis	0.000693	0.00308	CcSEcCtD
Rufinamide—Decreased appetite—Prednisone—ankylosing spondylitis	0.000684	0.00304	CcSEcCtD
Rufinamide—Rash—Prednisolone—ankylosing spondylitis	0.000683	0.00304	CcSEcCtD
Rufinamide—Dermatitis—Prednisolone—ankylosing spondylitis	0.000682	0.00304	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000682	0.00303	CcSEcCtD
Rufinamide—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00068	0.00303	CcSEcCtD
Rufinamide—Fatigue—Prednisone—ankylosing spondylitis	0.000679	0.00302	CcSEcCtD
Rufinamide—Headache—Prednisolone—ankylosing spondylitis	0.000679	0.00302	CcSEcCtD
Rufinamide—Constipation—Prednisone—ankylosing spondylitis	0.000673	0.00299	CcSEcCtD
Rufinamide—Dizziness—Triamcinolone—ankylosing spondylitis	0.000659	0.00293	CcSEcCtD
Rufinamide—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000657	0.00292	CcSEcCtD
Rufinamide—Infection—Methotrexate—ankylosing spondylitis	0.000654	0.00291	CcSEcCtD
Rufinamide—Asthenia—Dexamethasone—ankylosing spondylitis	0.000649	0.00288	CcSEcCtD
Rufinamide—Asthenia—Betamethasone—ankylosing spondylitis	0.000649	0.00288	CcSEcCtD
Rufinamide—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000645	0.00287	CcSEcCtD
Rufinamide—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000644	0.00287	CcSEcCtD
Rufinamide—Nausea—Prednisolone—ankylosing spondylitis	0.000643	0.00286	CcSEcCtD
Rufinamide—Pruritus—Dexamethasone—ankylosing spondylitis	0.00064	0.00284	CcSEcCtD
Rufinamide—Pruritus—Betamethasone—ankylosing spondylitis	0.00064	0.00284	CcSEcCtD
Rufinamide—Skin disorder—Methotrexate—ankylosing spondylitis	0.000639	0.00284	CcSEcCtD
Rufinamide—Vomiting—Triamcinolone—ankylosing spondylitis	0.000633	0.00282	CcSEcCtD
Rufinamide—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000632	0.00281	CcSEcCtD
Rufinamide—Rash—Triamcinolone—ankylosing spondylitis	0.000628	0.00279	CcSEcCtD
Rufinamide—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000628	0.00279	CcSEcCtD
Rufinamide—Anorexia—Methotrexate—ankylosing spondylitis	0.000627	0.00279	CcSEcCtD
Rufinamide—Rash—Methylprednisolone—ankylosing spondylitis	0.000627	0.00279	CcSEcCtD
Rufinamide—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000626	0.00279	CcSEcCtD
Rufinamide—Headache—Triamcinolone—ankylosing spondylitis	0.000624	0.00278	CcSEcCtD
Rufinamide—Headache—Methylprednisolone—ankylosing spondylitis	0.000623	0.00277	CcSEcCtD
Rufinamide—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000618	0.00275	CcSEcCtD
Rufinamide—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000618	0.00275	CcSEcCtD
Rufinamide—Dizziness—Dexamethasone—ankylosing spondylitis	0.000598	0.00266	CcSEcCtD
Rufinamide—Dizziness—Betamethasone—ankylosing spondylitis	0.000598	0.00266	CcSEcCtD
Rufinamide—Insomnia—Methotrexate—ankylosing spondylitis	0.000595	0.00265	CcSEcCtD
Rufinamide—Nausea—Triamcinolone—ankylosing spondylitis	0.000592	0.00263	CcSEcCtD
Rufinamide—Nausea—Methylprednisolone—ankylosing spondylitis	0.00059	0.00263	CcSEcCtD
Rufinamide—Somnolence—Methotrexate—ankylosing spondylitis	0.000585	0.0026	CcSEcCtD
Rufinamide—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00058	0.00258	CcSEcCtD
Rufinamide—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000579	0.00258	CcSEcCtD
Rufinamide—Vomiting—Betamethasone—ankylosing spondylitis	0.000575	0.00256	CcSEcCtD
Rufinamide—Vomiting—Dexamethasone—ankylosing spondylitis	0.000575	0.00256	CcSEcCtD
Rufinamide—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000572	0.00254	CcSEcCtD
Rufinamide—Rash—Dexamethasone—ankylosing spondylitis	0.00057	0.00254	CcSEcCtD
Rufinamide—Rash—Betamethasone—ankylosing spondylitis	0.00057	0.00254	CcSEcCtD
Rufinamide—Dermatitis—Betamethasone—ankylosing spondylitis	0.000569	0.00253	CcSEcCtD
Rufinamide—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000569	0.00253	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000568	0.00253	CcSEcCtD
Rufinamide—Fatigue—Methotrexate—ankylosing spondylitis	0.000567	0.00252	CcSEcCtD
Rufinamide—Headache—Dexamethasone—ankylosing spondylitis	0.000566	0.00252	CcSEcCtD
Rufinamide—Headache—Betamethasone—ankylosing spondylitis	0.000566	0.00252	CcSEcCtD
Rufinamide—Asthenia—Prednisone—ankylosing spondylitis	0.000565	0.00251	CcSEcCtD
Rufinamide—Pruritus—Prednisone—ankylosing spondylitis	0.000557	0.00248	CcSEcCtD
Rufinamide—Diarrhoea—Prednisone—ankylosing spondylitis	0.000539	0.0024	CcSEcCtD
Rufinamide—Nausea—Betamethasone—ankylosing spondylitis	0.000537	0.00239	CcSEcCtD
Rufinamide—Nausea—Dexamethasone—ankylosing spondylitis	0.000537	0.00239	CcSEcCtD
Rufinamide—Dizziness—Prednisone—ankylosing spondylitis	0.000521	0.00232	CcSEcCtD
Rufinamide—Vomiting—Prednisone—ankylosing spondylitis	0.000501	0.00223	CcSEcCtD
Rufinamide—Rash—Prednisone—ankylosing spondylitis	0.000496	0.00221	CcSEcCtD
Rufinamide—Dermatitis—Prednisone—ankylosing spondylitis	0.000496	0.00221	CcSEcCtD
Rufinamide—Headache—Prednisone—ankylosing spondylitis	0.000493	0.00219	CcSEcCtD
Rufinamide—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000485	0.00216	CcSEcCtD
Rufinamide—Asthenia—Methotrexate—ankylosing spondylitis	0.000472	0.0021	CcSEcCtD
Rufinamide—Nausea—Prednisone—ankylosing spondylitis	0.000468	0.00208	CcSEcCtD
Rufinamide—Pruritus—Methotrexate—ankylosing spondylitis	0.000465	0.00207	CcSEcCtD
Rufinamide—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00045	0.002	CcSEcCtD
Rufinamide—Dizziness—Methotrexate—ankylosing spondylitis	0.000435	0.00194	CcSEcCtD
Rufinamide—Vomiting—Methotrexate—ankylosing spondylitis	0.000418	0.00186	CcSEcCtD
Rufinamide—Rash—Methotrexate—ankylosing spondylitis	0.000415	0.00185	CcSEcCtD
Rufinamide—Dermatitis—Methotrexate—ankylosing spondylitis	0.000414	0.00184	CcSEcCtD
Rufinamide—Headache—Methotrexate—ankylosing spondylitis	0.000412	0.00183	CcSEcCtD
Rufinamide—Nausea—Methotrexate—ankylosing spondylitis	0.000391	0.00174	CcSEcCtD
